PL415646A1 - Concentration of copper in blood and changes within CAT gene as risk factors for cancers in women - Google Patents
Concentration of copper in blood and changes within CAT gene as risk factors for cancers in womenInfo
- Publication number
- PL415646A1 PL415646A1 PL415646A PL41564615A PL415646A1 PL 415646 A1 PL415646 A1 PL 415646A1 PL 415646 A PL415646 A PL 415646A PL 41564615 A PL41564615 A PL 41564615A PL 415646 A1 PL415646 A1 PL 415646A1
- Authority
- PL
- Poland
- Prior art keywords
- concentration
- copper
- cancers
- women
- cat
- Prior art date
Links
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 title abstract 5
- 229910052802 copper Inorganic materials 0.000 title abstract 5
- 239000010949 copper Substances 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 101150055766 cat gene Proteins 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 210000002966 serum Anatomy 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 2
- 239000012620 biological material Substances 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
W zgłoszeniu stwierdzono, że występuje korelacja między genotypem C-262T w genie CAT (rs1001179), poziomem miedzi w surowicy a ryzykiem raków u kobiet w Polsce. Przedmiotem zgłoszenia jest sposób określania ryzyka raka, charakteryzujący się tym, że obejmuje ocenę konstytucyjnej zmiany w genie CAT C-262T (rs 1001179) oraz ocenę stężenia miedzi w próbce biologicznej badanej kobiety, przy czym kombinacja poszczególnych genotypów z określonym stężeniem miedzi wskazuje znacząco obniżone ryzyko rozwoju raków: - dla genotypu CAT nCC przy stężeniu miedzi w surowicy 1200-1350 µg/l (lub stężeniu w dowolnym materiale biologicznym odpowiadającym stężeniu w surowicy).The application states that there is a correlation between the C-262T genotype in the CAT gene (rs1001179), serum copper levels and the risk of cancer in women in Poland. The subject of the application is a method for determining the risk of cancer, characterized in that it includes the assessment of the constitutional change in the CAT C-262T gene (rs 1001179) and the assessment of copper concentration in the biological sample of the examined woman, where the combination of individual genotypes with a specific concentration of copper indicates a significantly reduced risk development of cancers: - for the CAT nCC genotype at a serum copper concentration of 1200-1350 µg / l (or concentration in any biological material corresponding to serum concentration).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL415646A PL415646A1 (en) | 2015-12-30 | 2015-12-30 | Concentration of copper in blood and changes within CAT gene as risk factors for cancers in women |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL415646A PL415646A1 (en) | 2015-12-30 | 2015-12-30 | Concentration of copper in blood and changes within CAT gene as risk factors for cancers in women |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL415646A1 true PL415646A1 (en) | 2017-07-03 |
Family
ID=59201211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL415646A PL415646A1 (en) | 2015-12-30 | 2015-12-30 | Concentration of copper in blood and changes within CAT gene as risk factors for cancers in women |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL415646A1 (en) |
-
2015
- 2015-12-30 PL PL415646A patent/PL415646A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR105618A1 (en) | METHODATION OF THE PROMOTER OF THE BINDING TO THE PROGRAMMED DEATH RECEIVER (PD-L1) IN CANCER | |
| WO2019213282A8 (en) | Biomarkers for evaluating car-t cells to predict clinical outcome | |
| MX2018012580A (en) | Methods and kits for the diagnosis and risk stratification of patients with ischemia. | |
| EP3236262A3 (en) | Surrogate functional diagnostics test for cancer | |
| CR20190574A (en) | Diagnostic assays for detecting, quantifying, and/or tracking microbes and other analytes | |
| TR201907389T4 (en) | Method for the prognosis and treatment of bone cancer with metastases caused by breast cancer. | |
| NZ629074A (en) | Biomarkers for gastric cancer and uses thereof | |
| MY193895A (en) | Combination test for colorectal cancer | |
| Leung et al. | Ovarian cancer biomarkers: current state and future implications from high-throughput technologies | |
| NZ722492A (en) | Specific biomarker set for non-invasive diagnosis of liver cancer | |
| MX2015011804A (en) | Methods and compositions for diagnosing preeclampsia. | |
| PL415646A1 (en) | Concentration of copper in blood and changes within CAT gene as risk factors for cancers in women | |
| PL415643A1 (en) | Concentration of iron in blood and changes within GPX1 gene as risk factors for cancers in women | |
| PL415632A1 (en) | Concentration in blood and changes within IL6 gene as risk factors for cancers in women | |
| PL415639A1 (en) | Concentration of iron in blood and changes within SEP15 gene as risk factors for cancers in women | |
| PL414266A1 (en) | Concentration of selenium in blood as a risk factor for cancers in women | |
| PL415645A1 (en) | Concentration of zinc in blood and changes within MMP1 gene as risk factors for cancers in women | |
| PL415640A1 (en) | Concentration of iron in blood and changes within HFE gene as risk factors for cancers in women | |
| NZ714014A (en) | Therapeutic effect prediction method for colorectal cancer patient in whom expression of tk1 protein has increased | |
| PL414268A1 (en) | Concentration of zinc in blood within IL6 gene as risk factors for cancers in women | |
| PL415635A1 (en) | Concentration of zinc in blood and changes within GPX1 gene, as risk factors for breast or ovary cancers in carriers of BRCA1 mutation, subjected to the uterine adnexa removal operation | |
| PL414265A1 (en) | Concentration of copper in blood as a risk factor for extramammary breast cancers in women | |
| PL415642A1 (en) | Concentration of iron in blood and changes within HFE gene as risk factors for cancers in men | |
| PL415634A1 (en) | Concentration of selenium in blood as a risk factor for cancers in men | |
| PL415636A1 (en) | Concentration of iron in blood as a risk factor for cancers in men |